Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;84(3):e149-e150.
doi: 10.1016/j.jaad.2020.11.045. Epub 2020 Nov 27.

Reply to comment on: The Gabrin sign

Carlos Gustavo Wambier  1 , Sergio Vaño-Galván  2 , Andy Goren  3
Affiliations
Comment

Reply to comment on: The Gabrin sign

Carlos Gustavo Wambier et al. J Am Acad Dermatol. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None disclosed.

Comment on

  • Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".
    Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Fonda-Pascual P, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A. Wambier CG, et al. J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22. J Am Acad Dermatol. 2020. PMID: 32446821 Free PMC article.
  • Comment on: The Gabrin sign.
    Trüeb RM, van Neste D, Gavazzoni Dias MFR, Kopera D, Lee WS, Ioannides D, Rezende HD, Fellas AR, Uribe NC. Trüeb RM, et al. J Am Acad Dermatol. 2021 Mar;84(3):e147-e148. doi: 10.1016/j.jaad.2020.11.046. Epub 2020 Nov 27. J Am Acad Dermatol. 2021. PMID: 33253850 Free PMC article. No abstract available.

References

    1. Trüeb R.M., van Neste D., Gavazzoni Dias M.F.R. Comment on: the Gabrin sign. J Am Acad Dermatol. 2021 doi: 10.1016/j.jaad.2020.11.046. - DOI - PMC - PubMed
    1. Goren A., McCoy J., Wambier C.G. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020;33(4):e13365. - PMC - PubMed
    1. Lazzeri M., Azzolini E., Buffi N.M., Fasulo V. Impact of anti-androgenic therapies on COVID-19: an observational study in male population from a COVID-19 regional centre of Lombardy (Italy) MedRxiv. 2020 doi: 10.1101/2020.04.20.20068056. preprint. - DOI
    1. Wambier C.G., Mehta N., Goren A., Cadegiani F.A. COVID-19, androgens, and androgenic alopecia. Dermatological Rev. 2020 doi: 10.1002/der2.50. - DOI
    1. McCoy J., Cadegiani F.A., Wambier C.G. 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.17021. jdv.17021. - DOI - PubMed